All News

Measles Outbreak Explained: Disease History, Vaccine Breakthrough and 2025 Resurgence
February 27, 2025

The 2025 measles outbreak in Texas has reignited discussion surrounding vaccine-preventable diseases and the importance of maintaining high immunization rates.

Study Finds Telehealth Use in Depression Skews Towards Higher-Wealth Patients
February 27, 2025

Patients with depression from high-wealth areas were 1.62 times more likely in primary care and 1.67 times more likely in psychiatry to use telehealth.

FDA Accepts Supplemental New Drug Application for Uzedy for Bipolar I Disorder
February 27, 2025

The FDA accepted the sNDA for risperidone (Uzedy) extended-release injectable suspension for the maintenance treatment of bipolar I disorder in adults.

Transdermal Peanut Patch Shows Lasting Allergy Benefits: Daily Dose
February 27, 2025

Your daily dose of the clinical news you may have missed.

Focus on AAD 2025: Dermatologist Mona Shahriari, MD, Highlights the PCP Role in Atopic Dermatitis Care
February 27, 2025

Not all atopic dermatitis requires treatment by a specialist, says this dermatologist, and she collaborates regularly with her primary care colleagues.

Zonisamide Shows Promise for Hard-to-Treat Migraine in Children, Adolescents
February 27, 2025

While the data on zonisamide efficacy for migraine in youths is preliminary, all study participants experienced a 66% reduction in headaches after 1 month of treatment.

Measles Claims Life of Unvaccinated Texas Schoolchild, First US Fatality Reported Since 2015
February 27, 2025

A rural west Texas "undervaccinated" Mennonite community is the epicenter of the worst measles outbreak in the state in 30 years, the state health department reported.

Would you Know Measles if You Saw It?
February 27, 2025

A case of measles is a very rare diagnosis in the 21st century, but as MMR vaccination rates fall, the cases climb. Would you recognize the signs & symptoms?

FDA Approves Pentavalent Meningococcal Vaccine Penmenvy: Daily Dose
February 27, 2025

Your daily dose of the clinical news you may have missed.

Home-Based Therapy Achieves 100% Success Rate in Children with High-Threshold Peanut Allergy
February 26, 2025

AAAAI 2025: Phase 2 study results showed POIT with home-measured peanut products was not only highly effective but also posed few risks.